Real-world approaches to outpatient treatment of status migrainosus: A survey study
SM is defined as a debilitating migraine attack lasting more than 72 h. There is no standard of care for SM, including whether a 72-h duration is required before the attack can be treated as SM.
Health equity, care access and quality in headache – part 1
Current definitions of migraine that are based mainly on clinical characteristics do not account for other patient’s features such as those related to an impaired quality of life, due to loss of social life and productivity, and the differences related to the geographical distribution of the disease and cultural misconceptions which tend to underestimate migraine as a psychosocial rather than neurobiological disorder.
Consenso da Sociedade Brasileira de Cefaleia (SBCe) para o tratamento profilático da migrânea episódica: parte 1
The Brazilian Headache Society (Sociedade Brasileira de Cefaleia, SBCe, in Portuguese) nominated a Committee of Authors with the aim of establishing a consensus with recommendations regarding prophylactic treatment for episodic migraine based on articles published in the worldwide literature, as well as personal experience.
The global brain health clinical exchange platform: Traduzindo conceitos para colaborações – Journal of the Neurological Sciences
Two recent editorials from the World Health Organization (WHO) Brain Health Unit [ [1] ] and World Federation of Neurology (WFN) [ [2] ] outline the urgent need to optimise brain health using a collaborative approach.
Atualizações no manejo de Hipertensão Intracraniana Idiopática – PubMed
Idiopathic Intracranial Hypertension (IIH) is a secondary headache with a steadily growing incidence. Currently, there is little evidence to guide the treatment of IIH.
